2005 - 2006 Head of Clinical and Preclinical Oncology @ Inotek Pharmaceuticals
Mark Levitt Education
National Cancer Institute, NIH
Fellowship (Medical Oncology)
1984 - 1987
Hahnemann University
Residency (Internal Medicine)
1982 - 1984
Hahnemann University
1981 - 1982
Temple University - Lewis Katz School of Medicine
PhD (Pathology)
1973 - 1981
Temple University - Lewis Katz School of Medicine
MD (Medicine)
1974 - 1978
Temple University
BA (Interdisciplinary and Hebrew)
1970 - 1973
Mark Levitt Skills
Oncology
Clinical Trials
Biotechnology
Molecular Biology
Cancer
Clinical Research
Clinical Development
Pharmaceuticals
Research
Science
Mark Levitt Summary
Mark Levitt, based in Jerusalem District, Israel, is currently a Chief Scientific Officer at RedHill Biopharma Ltd.. Mark Levitt brings experience from previous roles at RedHill Biopharma Ltd., Levitt Oncology Associates, Ltd., Matrix BioTherapies and EnGeneIC. Mark Levitt holds a 1984 - 1987 Fellowship in Medical Oncology @ National Cancer Institute, NIH. With a robust skill set that includes Oncology, Clinical Trials, Biotechnology, Molecular Biology, Cancer and more. Mark Levitt has 3 emails on RocketReach.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.